About Us
We are a team of expert professionals who assist our clients to grow their medical cannabis business providing guidance throughout all investment phases.
Successful completion of our clients’ projects is our top priority.
Feel free to contact
Call us at : +30 2106835560
Send email to : info@vkmedicalcannabis.com
Our Services
We provide integrated Services throughout the process of the cannabis investment from Licensing and strategic planning to facility build up and product distribution.
Strategic Planning
Medical Cannabis Business, Market & Products trends
Strategic business modeling
Regulatory/Compliance consulting
Company establishment
Guidelines on Company’s eligibility for Grants (up to 55%)
Investments - Funding
Creation of partnerships (joint venture schemes)
Application files to receive Grants
Creation of partnerships (joint venture schemes)
Land Identification
Land plot portfolio
Land plot evaluation
Land legal and operational compliance
Product Distribution
Distribution strategy
Wholesale agreements
Monitoring of pricing policies & market trends
Security
Design of SOPs & equipment
Sourcing of equipment
Transportation solutions
Project Management
Classification of activities to sequential one vs the ones to be done in parallel
Suppliers evaluation taking into account the delivery time of ordered equipment
Blog
February 9, 2021
JAZZ Pharma acquires GW Pharma in a $7.2 Billion Deal - The biggest medical cannabis acquisition so far. GW Pharma owns Epidiolex the world’s most popular cannabis based medicine.
January 19, 2021
We analyze and present the most important industry trends of the European & global market for medical cannabis & CBD products for 2021. Which are the major challenges and opportunities?
December 8, 2020
The UN has recently accepted recommendations made by the World Health Organization which reschedule cannabis and cannabis related substances, effectively accepting the medical potential of cannabis.
December 8, 2020
Following the ruling of the Court of Justice of the European Union (CJEU), the European Commission decided that cannabidiol (CBD) will not be regulated as a drug and can be qualified as food.
September 8, 2020
The steadily increasing competition in this market has made particularly crucial the initial investor’s decisions for setting up a successful Medical Cannabis facility. The 5 most critical decisions for the investor.
September 8, 2020
There is constant increase in the UK’s demand for medical cannabis. That reveals an opportunity for EU Medical Cannabis Companies aiming to export in other EU countries.